Viewing Study NCT01074593


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-02-25 @ 7:02 PM
Study NCT ID: NCT01074593
Status: COMPLETED
Last Update Posted: 2013-02-25
First Post: 2009-11-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy Subjects
Sponsor: Azidus Brasil
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: INTBER0609
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Alexandre Frederico
Old Organization: LAL Clinica Pesquisa e Desenvolvimento Ltda

Collaborators